Studien und Publikationen
2026
Clinical Infectious Diseases (2026). - A Case of Delayed Detection of Vertical Transmission of HIV-1 due to Maternal Therapy With Long-Acting Injectable Cabotegravir Plus Rilpivirine.
Microbiology Spectrum 14, no. 4 (2026): e0030625. - Analytical and Clinical Evaluation of the Alinity m Resp-4-Plex Assay in Comparison to Two Singleplex SARS-CoV-2 Assays and One Multiplex Respiratory Assay.
Methods 251 (2026). - Digital PCR as a Potential Reference Measurement Procedure to Support Monkeypox Virus/Orthopoxvirus External Quality Assessment Schemes.
2025
ESCMID 2025 - P0025 / Evaluation of the new DxI 9000 Anti-HIV Antibody and Antigen Combo assay
ESCMID 2025 - P0056 / HDV full genome sequencing and genotype determination in a Berlin cohort
ESCMID 2025 - P0075 / Evaluation of the new DxI 9000 ACCESS anti-HCV assay
ESCMID 2025 - P0076 / Evaluation of the new DxI 9000 ACCESS HBsAg assay
ESCMID 2025 - P0359 / Sequencing of MPXV positive samples in Berlin 2022 to 2025
Nature 650, no. 8102 (2025): 701–709. - Sustained HIV-1 Remission after Heterozygous CCR5Δ32 Stem Cell Transplantation.
Blood 146, Supplement 1 (2025): 2484–2484. - Graft-versus-HIV-Reservoir Reactivity: Long Term HIV Remission after Allogeneic Stem Cell Transplantation from a Donor with Active CCR5.
The Lancet Microbe 6, no. 12 (2025): 10123. - Detection of H5N1 Clade 2.3.4.4b in External Quality Assessment Programmes: A Pandemic Preparedness Initiative.
International Journal of Medical Microbiology 319, no. 6 (2025): 151656. - From Crisis to Routine – Standardization of SARS-CoV-2 Genome Detection by Enhanced EQA Schemes in a Scientific Pandemic Network.
Clinical Infectious Diseases 81, no. 3 (2025): 539–542. - HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update.
Journal of Medical Virology 97, no. 2 (2025): e70169. - Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods.
2024
ECCMID 2024 - E0254/ Molecular detection of Neisseria gonorrhoeae resistance in a Berlin MSM cohort
ECCMID 2024 - P0170/ Evaluation of the performance of the Hologic Panther fusion 4 plex-assay
ESCV 2024 - PP-156/ Alinity m HSV 1 & 2 / VZV – a new qualitative multi-plex PCR test
ESCV 2024 - PP-157/ Viral load measurement in HIV-1 samples with highly mutated Integrases
Clinica Chimica Acta 558 (2024): 119103. - Droplet Digital PCR for Accurate Quantification and Detection of Outbreak Pathogens.
Journal of Virological Methods 327, no. 4 (2024): 114937. - Real-World Performance of the NeuMoDx™ HCV Quant Test for Quantification of Hepatitis C Virus (HCV)-RNA.
2023
ECCMID 2023 - P2929/ Monkeypox virus (MPXV) outbreak in Berlin – Implementation of molecular diagnostics
ECCMID 2023 - ALP1204/ Implementation of genotypic resistance testing for Neisseria gonorrhoeae in a multiplex-PCR
ESCV 2023 - 048/ Evaluation of the performance of the Alinity m MPXV Assay
ESCV 2023 - 011/ Comparison of PBMC extraction methods to improve SARS-CoV-2 T cell research
DÖAK 2023 - Niedrige Medikamentenspiegel nach Injektionen von langwirksamem Rilpivirin
DÖAK 2023 - 81340/ Monkeypox virus (MPXV) outbreak in Berlin – Implementation of molecular diagnostics
CROI 2023 - 954/ MPOX virus (MPXV) outbreak in Berlin – Implementation of molecular diagnostics
Nephrology Dialysis Transplantation 39, no. 3 (2023): 483–495. - Plasma NGAL Levels in Stable Kidney Transplant Recipients and the Risk of Allograft Loss.
Scientific Reports 13, no. 1 (2023). - Results of German External Quality Assessment Schemes for SARS-CoV-2 Antigen Detection.
PLOS ONE 18, no. 4 (2023): e0285203. - Results of the First German External Quality Assessment Scheme for the Detection of Monkeypox Virus DNA.
2022
ECCMID 2022 - P2216/ SARS-CoV-2antibody levels after vaccination and booster in different vaccination regimen
ESCV 2022 - PP-221/ Antibody levels against SARS-CoV-2 after vaccination and booster in different vaccination regimens
ESCV 2022 - PP-146/ Evaluation of the performance of the high-throughput multiplex Alinity m Resp-4-Plex assay
Journal of Clinical Virology* 149 (2022): 105127. - Performance Assessment of the New Xpert® HIV-1 Viral Load XC Assay for Quantification of HIV-1 Viral Loads.
PLOS ONE* 17, no. 1 (2022): e0262656. - RNA Reference Materials with Defined Viral RNA Loads of SARS-CoV-2—A Useful Tool towards a Better PCR Assay Harmonization.
Journal of Virological Methods* 299 (2022): 114338. - Clinical Evaluation of the Automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex Assays.
2021
ECCMID 2021 - 03132/ Performance of Abbott Alinity m and RealTime SARS-CoV-2 assays in clinical practice
ECCMID 2021 - 03002/ Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement
ESCV 2021 - P176/ Performance of the new Abbott Realtime SARS-CoV-2 assay
ESCV 2021 - P160/ Evaluation of the new Alinity m Resp-4-Plex assay
ESCV 2021 - P159/ Pool testing from throat wash and nasopharyngeal swabs for SARS-CoV-2 RNA with high sensitivity
Experimental and Clinical Endocrinology & Diabetes* 129, no. 11 (2021): 798–802. - Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV Infection.
Journal of Laboratory Medicine* 45, no. 4–5 (2021): 213–223. - Simultaneous Identification of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis – Multicenter Evaluation of the Alinity m STI Assay.
MMW – Fortschritte der Medizin* 163, no. S2 (2021): 28–35. - Vergleich der HIV-Therapie im städtischen und ländlichen Raum.
Journal of Clinical Virology* 136 (März 2021): 104755. - Adapting the Geno2pheno [Coreceptor] Tool to HIV-1 Subtype CRF01_AE by Phenotypic Validation Using Clinical Isolates from South-East Asia.
Frontiers in Medicine* 7 (3. Februar 2021): 616648. - Preventing SARS-CoV-2 In-Hospital Infections in Cardiovascular Patients and Medical Staff: An Observational Study From the German Heart Center Berlin.
Clinical Infectious Diseases* 72, no. 3 (1. Februar 2021): 503–509. - Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.
2020
Journal of Laboratory Medicine* 44, no. 6 (2020): 319–328. - Improved Molecular Laboratory Productivity by Consolidation of Testing on the New Random-Access Analyzer Alinity m.
Journal of Clinical Virology* 129 (2020): 104531. - Multicenter Clinical Evaluation of Alinity m HCV Assay Performance.
Journal of Clinical Virology* 129 (2020): 104514. - Multicenter Clinical Evaluation of Alinity m HBV Assay Performance.
Journal of Clinical Virology* 129 (2020): 104530. - Multicenter Clinical Comparative Evaluation of Alinity m HIV-1 Assay Performance
Journal of Virological Methods* 279 (2020): 113839. - Comparison of Two Immunoassays for Concurrent Detection of HCV-Antigen and Antibodies among HIV/HCV Co-Infected Patients in Dried Serum/Plasma Spots.
Journal of Immunological Methods* 479 (2020): 112744. - Establishment of an Anti-Hepatitis C Virus IgG Avidity Test for Dried Serum/Plasma Spots.
2019
GfV 2019 - Establishment of anti-Hepatitis C Virus IgG Avidity Test for Dried Serum/Plasma Spots
EMMD 2019 - 48/ Integrating genotypic HIV tropism testing into the Vela Sentosa HIV genotyping and resistance assay
New England Journal of Medicine* 381, no. 9 (2019): 887–889. - Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R.
Rober-Koch-Institut (2019) - Gonorrhö mit einem high-level-Azithromycin-resistenten Erreger in Deutschland.
2018
Nucleic Acids Research* 46, no. W1 (2018): W271–W277. - Geno2pheno[Ngs-Freq]: A Genotypic Interpretation System for Identifying Viral Drug Resistance Using Next-Generation Sequencing Data.
2017
Journal of Viral Hepatitis* 24, no. 10 (2017): 832–839. - HIV-Positive Men Who Have Sex with Men Are at High Risk of Development of Significant Liver Fibrosis after an Episode of Acute Hepatitis C.
2016
CROI 2016 - 525/ Comparison of Four HCV Viral Load Assays at High Viral Load
ESCV Lissabon 2016 - PP40/ Comparison of the recently launched Hologic Aptima HBV Quant assay with the established Abbott RealTime HBV assay in viral load measurement
eurDrugRes Rom 2016 - O-04/ Next generation sequencing in routine HIV-1 resistance diagnostic - frequency of additional resistance relevant mutations in 2% and 1% population proportions
HIV Glasgow 2016 - P358/ Frequency of additional resistance relevant mutations in 2% and 1% population proportions in next generation sequencing in routine HIV-1 resistance diagnostics
Zeitschrift für Gastroenterologie* 54, no. 12 (2016): 1343–1404. - Detection of a Genetic Footprint of the Sofosbuvir Resistance-Associated Substitution S282T after HCV Treatment Failure.
Journal of Clinical Virology* 82 (2016): S41. - Comparison of the Recently Launched Hologic Aptima HBV Quant Assay with the Established Abbott RealTime HBV Assay in Viral Load Measurement.
Journal of Clinical Virology* 81 (2016): 82–89. - New Findings in HCV Genotype Distribution in Selected West European, Russian and Israeli Regions.
Clinics and Research in Hepatology and Gastroenterology* 40, no. 3 (2016): e23–e25. - Persisting Hepatitis E Virus Infection Leading to Liver Cirrhosis despite Recovery of the Immune System in an HIV-Infected Patient.
PLOS ONE* 11, no. 5 (2016): e0155869. - Geno2pheno[HCV] – A Web-Based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.
2015
EMMD Nordwijk 2015 - The newly developed Cepheid Xpert® HIV-1 VL compared to the established Abbott RealTime HIV-1 viral load measurement
EMMD Nordwijk 2015 - Hologic Aptima HIV-1 Quant Dx Assay Compared to Abbott RealTime in B and non-B Subtypes in daily routine testing
Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz* 58, no. 8 (2015): 877–886. - Nachweis einer Infektion mit Humanem Immundefizienzvirus (HIV): Serologisches Screening mit nachfolgender Bestätigungsdiagnostik durch Antikörper-basierte Testsysteme und/oder durch HIV-Nukleinsäure-Nachweis: Stellungnahme der Gemeinsamen Diagnostikkommission der Deutschen Vereinigung zur Bekämpfung von Viruskrankheiten e. V. (DVV e. V.) und der Gesellschaft für Virologie e. V. (GfV e. V.).
2014
Intervirology* 57, no. 3–4 (2014): 232–236. - Hepatitis B Virus Drug Resistance Tools: One Sequence, Two Predictions.
Journal of the International AIDS Society* 17, no. 4, Suppl. 3 (2014). - Safety Analysis of Raltegravir/Truvada Regimen in HIV/HCV Co-Infected Patients without Switchback after HCV-Treatment.
Journal of the International AIDS Society* 17, no. 4, Suppl. 3 (2014). - New Dolutegravir Resistance Pattern Identified in a Patient Failing Antiretroviral Therapy.
Journal of the International AIDS Society* 17, no. 4, Suppl. 3 (2014). - Appearance of NS3 Q80K Mutation in HCV Genotype 1a Mono- or HIV/HCV Co-Infected Patients in a Berlin Laboratory.
Journal of the International AIDS Society* 17, no. 4, Suppl. 3 (2014). - Resistance Remains a Problem in Treatment Failure.
HIV Medicine* 15, no. 6 (2014): 355–361. - Multiple Hepatitis C Virus (HCV) Reinfections in HIV-Positive Men Who Have Sex with Men: No Influence of HCV Genotype Switch or Interleukin-28B Genotype on Spontaneous Clearance.
2013
Clinical Infectious Diseases* 56, no. 11 (2013): 1654–1658. - HIV-2EU: Supporting Standardized HIV-2 Drug Resistance Interpretation in Europe.
2012
Journal of the International AIDS Society* 15, Suppl. 4 (2012): 18417. - Ménage à Trois: Increased Prevalence of Syphilis Infection in HIV-Positive MSM with Acute Hepatitis C.
Intervirology* 55, no. 2 (2012): 102–107. - HIVGRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge.
Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Activation and Inflammation Markers in HIV-1-Infected Patients in Dependency of Treatment Strategies.
Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Sexually Transmitted Infection with an Immune-Escape Mutant Hepatitis B Virus (HBV) in an HBV-Vaccinated Individual with Acute HIV-HCV Infection.
Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - HIV-1 Drug Resistance Testing at Low Viral Load May Help to Differentiate between Ongoing Replication and Release from Reservoirs.
Journal of the International AIDS Society* 15, no. 6, Suppl. 4 (2012). - Genotypic HIV-Coreceptor Tropism Prediction with Geno2pheno [Coreceptor]: Differences Depending on HIV-1-Subtype.
Current Opinion in HIV and AIDS* 7, no. 5 (2012): 470–477. - HIV Population Genotypic Tropism Testing and Its Clinical Significance.
Journal of Clinical Virology* 54, no. 3 (2012): 279–281. - The Detection of HBsAg Mutants Expressed in Vitro Using Two Different Quantitative HBsAg Assays.
Medical Microbiology and Immunology* 201, no. 1 (2012): 7–16. - APOBEC3G/F as One Possible Driving Force for Co-Receptor Switch of the Human Immunodeficiency Virus-1.
2011
Antiviral Therapy* 16, no. 6 (2011): 815–824. - Considerable Under-Treatment of Chronic HCV Infection in HIV Patients despite Acceptable Sustained Virological Response Rates in a Real-Life Setting.
European Journal of Medical Research* 16, no. 5 (2011): 237–242. - Acute Hepatitis C in Persons Infected with the Human Immunodeficiency Virus (HIV): The ‘Real-Life Setting’ Proves the Concept.
HIV Medicine* 12, no. 4 (2011): 211–218. - Prediction of Response to Antiretroviral Therapy by Human Experts and by the EuResist Data-Driven Expert System (the EVE Study): EuResist vs. Experts (EVE) Study.
2010
Journal of the International AIDS Society* 13, Suppl. 4 (2010): P129. - Clinical Application of Genotypic Co-Receptor Tropism Testing from Viral RNA and Proviral DNA: Week 24 Analysis of the Berlin Maraviroc Cohort.
2009
Infection Control & Hospital Epidemiology* 30, no. 3 (2009): 299–300. - Late Appearance of Hepatitis C Virus RNA After Needlestick Injury: Necessity for a More Intensive Follow-Up.
2008
Journal of the International AIDS Society* 11, Suppl. 1 (2008): P201. - Determination of HIV-1 Co-Receptor Usage in German Patients – Comparison of Genotypic Methods with the TROFILE® Phenotypic Assay.
2007
PLoS ONE 2, no. 7 (2007) - Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection.